Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Time to recurrence and its relation to survival after recurrence in patients resected for stage III colon cancer.

European journal of cancer (Oxford, England : 1990) - 1 Nov 2023

Rasola Cosimo, Laurent-Puig Pierre, André Thierry, Falcoz Antoine, Lepage Come, Aparicio Thomas, Bouché Olivier, Lievre Astrid, Mineur Laurent, Bennouna Jaafar, Louvet Christophe, Bachet Jean Baptiste, Borg Christophe, Vernerey Dewi, Lonardi Sara, Taieb Julien

Abstract excerpt

BACKGROUND: It is intuitively thought that early relapse is associated with poor survival after recurrence (SAR) in resected colon cancer (CC) patients, but this has never been formally studied. METHODS: We pooled data from stage III patients treated with oxaliplatin-based adjuvant therapy in two phase III trials, to analyse time to recurrence (TTR) and its relationship with SAR. TTR and SAR were also studied...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Colonic Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Mismatch Repair

Share to Neoplasm Staging

Share to Neoplastic Syndromes, Hereditary

Share to Oxaliplatin

Share to Proto-Oncogene Proteins B-raf

Share to Recurrence

Source

Identifiers

PMID: 37797388
DOI: 10.1016/j.ejca.2023.113321

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Time to recurrence and its relation to survival after recurrence in patients resected for stage III colon cancer.PMID 37797388Read ↗

Association of DNA Mismatch Repair and Mutations in BRAF and KRAS With Survival After Recurrence in Stage III Colon Cancers : A Secondary Analysis of 2 Randomized Clinical Trials.Semantic proximity Read ↗

Clinicopathological characteristics and prognosis of patients according to recurrence time after curative resection for colorectal cancer.Semantic proximity Read ↗

RAS Mutations Predict Recurrence-Free Survival and Recurrence Patterns in Colon Cancer: A Unicenter Study in Morocco.Semantic proximity Read ↗

Using ctDNA to Predict Recurrence After Surgery in Stage II–III Colorectal Cancer: A Systematic Review and Narrative Meta-AnalysisSemantic proximity Read ↗

The Effect of RAS/BRAF Mutation Status on Prognosis and Relapse Pattern in Early Stage Colon Cancers.Semantic proximity Read ↗

Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer.Semantic proximity Read ↗

12-Gene Recurrence Score Assay Stratifies the Recurrence Risk in Stage II/III Colon Cancer With Surgery Alone: The SUNRISE Study.Semantic proximity Read ↗

KRAS Mutant Status May Be Associated with Distant Recurrence in Early-stage Rectal Cancer.Semantic proximity Read ↗

Cancer-associated fibroblast signature and SMAD4 mutation in resistance to adjuvant chemotherapy in stage III colon cancer patients.Semantic proximity Read ↗

The Effect of RAS/BRAF Mutation Status on Prognosis and Relapse Pattern in Early Stage Colon CancersSemantic proximity Read ↗

A New Surveillance Algorithm After Resection of Colorectal Liver Metastases Based on Changes in Recurrence Risk and RAS Mutation Status.Semantic proximity Read ↗

Node-negative colon cancer: histological, molecular, and stromal features predicting disease recurrence.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.